Also known as: OXM
Oxyntomodulin is a peptide hormone derived from proglucagon, primarily produced in the intestines. It is classified as a dual GLP-1/glucagon agonist, making it significant in the field of metabolic peptides. Oxyntomodulin plays a crucial role in regulating appetite and energy expenditure, positioning it as a potential target for weight management and metabolic health.
Oxyntomodulin functions by activating both GLP-1 (Glucagon-Like Peptide-1) and glucagon receptors, which leads to a complex interplay of metabolic effects.
Upon release, Oxyntomodulin enhances insulin secretion while simultaneously inhibiting glucagon release, contributing to improved glucose homeostasis. Additionally, it promotes satiety by acting on the central nervous system, thereby reducing food intake and increasing energy expenditure.
Oxyntomodulin is a promising peptide with dual action on GLP-1 and glucagon receptors, making it relevant in the study of fat loss and metabolic health. Its effects on appetite regulation and energy expenditure highlight its potential applications in obesity and diabetes research.
Last updated: Feb 25, 2026